← Evidence map

ArticleBlood vessels, thrombosis & hemostasis2026

Sustained response after rilzabrutinib discontinuation in multirefractory immune thrombocytopenia.

Tomás José González-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42157994